1 in 5: why the UK pharma industry is going to court over spending caps

GlaxoSmithKline, GSK, R&D facility, laboratory, Stevenage

Companies including GSK have said they might shift R&D centres to other countries if the UK becomes unattractive. Image courtesy of GlaxoSmithKline.

cachename:Featurescachekey:rd287061521_214423707_rd221744618_1079134950_rd-1665407042_727740091_rd-488908060_1008847663_